last authored: Jan 2010, David LaPierre
last reviewed:
Acute coronary syndrome describes three different conditions: heart attacks of two types - non-ST elevation myocardial infarction (NSTEMI), and ST elevation myocardial infarction (STEMI) - as well as another condition called unstable angina.
Each share a common initiating pathological event. Myocardial infarction (MI) refers to the death (infarction) of heart cells, while in unstable angina cell death has not occurred.
In Canada, 35% of deaths are due to CAD. Nearly 10% of MIs occur in people under the age of 40, and almost half affect people under 65%.
a simple case introducing clincial presentation and calling for a differential diagnosis to get students thinking.
Acute coronary syndromes typically result from atherosclerotic plaque disruption.
Risk factors for ACS therefore are those of atherosclerosis, and include:
More than 90% of ACS results from disruption of an atherosclerotic plaque, with subsequent platelet aggregation and thrombus formation. This leads to severe or complete occlusion of the vessel.
The other 10% are due to intense and prolonged vasospasm, sometimes related to cocaine abuse, emboli, or idiopathic.
Most often, ACS results from abrupt disruption of a previously only partially stenosed plaque, which undergoes any of the following:
Those that undergo abrupt disruption often are only mildly to moderately stenosed. A rather large number of asymptomatic adults therefore are at risk of ACS.
The triggering events are complex and poorly understood, but include plaque characteristics, blood pressure, and platelet reactivity. Adrenergic increases in blood pressure or local vasospasm can be lethal. Awakening and arising leads to the peak incidence of MI occurring between 6am-noon. Emotional stress can also contribute to plaque disruption, illustrated by the increase in sudden death following disasters.
It is increasingly clear that plaque disruption and thrombosis can occur in silent repetitive waves.
Inflammation is also very important throughout atherosclerosis. T cells produce TNF, IL-6, and IFN-gamma, stimulating endothelial cells and activating macrophages. Macrophage secretion of metalloproteinases weaken the fibrous cap and can lead to rupture.
Markers of inflammation such as C-reactive protein may be useful in estimating risk.
Vasoconstriction can be mediated by adrenergic factors, platelet activation, and possible inflammatory mediators.
Frequently, within minutes, the lumen is completely blocked.
Within seconds, aerobic glycolysis stops and lactic acid begins to breakdown. A striking loss of contractility occurs within 60 seconds of ischemia onset, which can precipitate heart failure long before infarction. Only severe ischemia lasting 20-40 minutes leads to cell death in the form of coagulation necrosis.
Most MIs are transmural, in which necrosis extends through the ventricular wall. A wavefront of cell death moves through the wall, and necrosis appears largely complete within 6 hours. Hearts with developed coronary arterial collaterals may take up to 12 hours to fully necrose.
The subendocardium is most susceptible to damage, and some MIs are limited to the inner half of the wall. Subendocardial infarctions can result from a thrombus which is lysed early after forming, but can also follow prolonged shock superimposed on nonruptured coronary stenosis.
Scarring is well advance after 6 weeks.
In unstable angina and NSTEMI, the vessel is usually not completely blocked, resulting in no or little necrosis. If the vessel is blocked, however, severe ischemia results in the significant necrosis accompanying STEMI.
Nearly all transmural infarcts involve at least a portion of the left ventricle, including the septum. About 15-30% of those affecting the posterior wall extend into the right atrium. Atrial tissue can sometimes become infarcted with large posterior wall infarcts.
LAD infarcts (40-50%) involve the anterior left ventricle near the apex, the anterior septum, and the apex circumferentially
RCA infarcts (30-40%) involve the inferior/posterior wall of the left ventricle, the posterior septum, and the right ventricular free wall
LCA infarcts (15-20%) involve the lateral wall of the left ventricle, except the apex.
Dyspnea can result from pulmonary congestion and edema.
In 10-15% of people, particuarly the elderly and those with diabetes, silent MIs are only discovered later by ECG changes, usually new Q waves.
People can have a rapid, weak pulse and are often sweating profusely.
Fatally injured myocytes leak proteins into the blood. These include myoglobin, troponins T and I, creatine kinase-MB, lactate dehydrogenase, and others. The preferred biomarkers are cardiac-specific, particularly the troponins. An absence of change in CK within 2 days essentially excludes MI. Reperfusion acceletates biopmarker presence due to enzyme washout.
troponin-T and I
myoglobin
cholesterol
BUN (kidneys)
Before reperfusion: protrombin time (PT) and partial thromboplastin time (PTT) to ensure extrinsic and intrinsic clotting pathways are ok
Perform ECG within 10 minutes of medical contact
ST depression
ST elevation
MI: biomarker evidence of necrosis (over 99th centile of upper reference limit) plus ischemic symptoms, new ischemic ECG changes, new pathological Qs, or imaging evidence of new loss of viable myocardium or new regional wall motion abnormality
if less than 12 h, with ST elevation or new LBBB
Within 90 minutes of presentation, PCI is preferable. Fibrinolytics may be given within 12 hours of onset of symptoms.
anti-thrombin therapy
approximately half the risk of death with ULMWH
enoxaparin is better
fondaparinux
bivalirudin
repurfusion
thrombolytics
absolute
relative
time is muscle, aim for a door to needle time below 30 minutes
stroke predictors include old age, female, low predictors etc
throbolytic therapy contraindicated in UA and NSTEMI
thrombolytics only work 45-50% of time
metaanalyisis shows field treatment with thrombolytics has a small benefit
Reperfusion can salvage tissue and limit infarction, as cell death takes 6-12 hours to fully occur. The first 3-4 hours are critical.
Reperfusion within the first 15-20 minutes can prevent all necrosis.
In-hospital mortality has declined from 30% in the 1960's to 10-13% today. Half of deaths occur within 1 hour of symptom onset.
Poor prognosis factors include advanced age, female gender, siebetes mellitus, and previous MI.
Nearly 75% of people have one or more complications, which include:
ventricular remodeling includes progressive changes in size, shape, and thickness of the heart, leading to initial benefit but later impairment.
ACS patients have a high early recurrence rate which then levels off. Treat aggressively early.
Reperfusion is the best way to salvage ischemic heart tissue, but can lead to arrhythmias, contraction bands (supercontraction of already dead cells), or reperfusion injury. This is mediated, at least in part, by free radicals.
Not dead ischemic myocardium can remain stunned or hibernate.
in NS, one year mortality:
UA: 8%
STEMI: 17%
NSTEMI: 22%
Case #2 - a small story wrapping it all up and asking especially about management.
any good free online resources for further reading.
created:
authors:
editors:
reviewers: